Covered recipient · General Payments record
JOSHUA JAMES STAGG
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$5,093.78
- Reported across 289 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $558.99 | 30 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $432.94 | 25 |
| GENZYME CORPORATION | $42.77 | 1 |
| Celgene Corporation | $33.63 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $28.64 | 1 |
| Janssen Biotech, Inc. | $21.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (30)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202020222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.65 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152125 | CMS |
| ABBVIE INC. | $20.53 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152127 | CMS |
| ABBVIE INC. | $23.06 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152129 | CMS |
| ABBVIE INC. | $17.76 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152131 | CMS |
| ABBVIE INC. | $21.63 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152133 | CMS |
| ABBVIE INC. | $14.15 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152135 | CMS |
| ABBVIE INC. | $19.03 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152137 | CMS |
| ABBVIE INC. | $17.16 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152139 | CMS |
| ABBVIE INC. | $12.88 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152141 | CMS |
| ABBVIE INC. | $24.59 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152143 | CMS |
| ABBVIE INC. | $15.45 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152145 | CMS |
| ABBVIE INC. | $18.55 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152147 | CMS |
| ABBVIE INC. | $17.74 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152149 | CMS |
| ABBVIE INC. | $18.71 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152151 | CMS |
| ABBVIE INC. | $10.07 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152153 | CMS |
| ABBVIE INC. | $15.46 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152155 | CMS |
| ABBVIE INC. | $17.03 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152157 | CMS |
| ABBVIE INC. | $11.36 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152159 | CMS |
| ABBVIE INC. | $19.17 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152161 | CMS |
| ABBVIE INC. | $13.17 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152163 | CMS |
| ABBVIE INC. | $11.69 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152165 | CMS |
| ABBVIE INC. | $23.63 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152167 | CMS |
| ABBVIE INC. | $13.90 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152169 | CMS |
| ABBVIE INC. | $18.26 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152171 | CMS |
| ABBVIE INC. | $20.31 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106152173 | CMS |
| Celgene Corporation | $19.09 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101090369 | CMS |
| Celgene Corporation | $14.54 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101090373 | CMS |
| GENZYME CORPORATION | $42.77 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139934799 | CMS |
| Janssen Biotech, Inc. | $21.01 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078777185 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $28.64 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137681247 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.